Research Article
Effect of Interleukin-15 on CD11b, CD54, and CD62L Expression on Natural Killer Cell and Natural Killer T-Like Cells in Systemic Lupus Erythematosus
Table 1
Characteristics of controls and patients with SLE.
| | Characteristics | Controls () | SLE patients () |
| | Sex (male/female) | 0/17 | 0/33 | | Age, mean (range) | 29.3 ± 0.9 (27–34) | 22.5 ± 0.9 (12–32) | | SLEDAI score, median (range) | NA | 7 (0~25) | | C3, median (range) | NA | 66.7 (21–106) | | C4, median (range) | NA | 9.7 (2.1–32.9) | | Anti-dsDNA, median (range) | NA | 309.9 (79.6–632.8) | | Average disease duration | NA | 8.9 ± 0.7 | | Taking regular corticosteroids | NA | 57.6% | | Cell population | | | | CD56+CD3- NK cells (%)# | 7.3 ± 0.9% | 4.4 ± | | CD56-CD3+ T cells (%) | 71.8 ± 1.4% | 67.2 ± 2.8% | | CD56+CD3+ NKT-like cells (%) | 3.5 ± 0.6% | 2.2 ± |
|
|
and compared to controls; #the percentages of NK cells, T cells, and NKT-like cells in total lymphocytes.
|
